DXR

Daxor Corporation · NASDAQ · Healthcare · USD · 10-K for 2011, filed 2012-03-28

Figures on this page computed 2026-11-08 12:58 UTC

Last close

8.91USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2011, filed 2012-03-28

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2011
Accession
0001019056-12-000401
Reported in
USD
- computed
- 10-K for 2011, filed 2012-03-28
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2011
Accession
0001019056-12-000401
Reported in
USD
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
The filing itself
-496.8%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2011
Accession
0001019056-12-000401
Reported in
USD
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
The filing itself
-458.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2011
Accession
0001019056-12-000401
Reported in
USD
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2011
Accession
0001019056-12-000401
Reported in
USD
- 10-K for 2011, filed 2012-03-28
- 10-K for 2011, filed 2012-03-28
The filing itself
n/aDividend yield
The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
- Computed from the filing for 2010

What it pays out is the furthest below its sector's middle: 0.04 against 0.50 on the market's range.

Five bars, one line

lens 7 of 9

0.79x

-2.83x

1.74x

n/a

0.90x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2011

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2011, filed 2012-03-28

Sales0.79x
Its own average over 10 years, 1.8M.
Profit-2.83x
Its own average over 10 years, 2.5M.
Free cash flow1.74x
Its own average over 10 years, -3.8M.
Debtn/a
Its own average over 9 years, 8.3M.
Price0.90x
Its own average over 11 years, 10. Market data, 2026-11-04

Profit is furthest from its own average, at -2.83 times.

Sales is 0.79 times its own 10-year average; Profit is -2.83 times its own 10-year average; Free cash flow is 1.74 times its own 10-year average; Price is 0.90 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2011, filed 2012-03-28

Sales against its own 10-year average0.79
Source
filed
Statement
income
Fiscal year
2011
Accession
0001019056-12-000401
Reported in
USD
The filing itself
Profit against its own 10-year average-2.83
Source
filed
Statement
income
Fiscal year
2011
Accession
0001019056-12-000401
Reported in
USD
The filing itself
Free cash flow against its own 10-year average1.74
Source
filed
Statement
income
Fiscal year
2011
Accession
0001019056-12-000401
Reported in
USD
The filing itself
Debt against its own 9-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2011
Accession
0001019056-12-000401
Reported in
USD
The filing itself
Price against its own 11-year average0.90Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD